Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Helen Of Troy (HELE) Q2 Earnings & Sales Beat, Stock Down

Published 10/09/2019, 08:23 AM
Updated 07/09/2023, 06:31 AM

Helen of Troy Limited (NASDAQ:HELE) released second-quarter fiscal 2020 results, wherein both top and bottom lines increased year over year and beat the Zacks Consensus Estimate. The company has been posting better-than-expected results for quite some time now. Management raised its overall sales and earnings outlook for fiscal 2020.

However, the company lowered its view for the Health & Home segment, which remained soft in the quarter under review as well. Unfavorable currency impacts were also a drag on Helen of Troy’s second-quarter performance. Shares of the company dipped 2.9% in yesterday’s trading session.

Results in Detail

Adjusted earnings from continuing operations improved 13.1% year over year to $2.24 per share, which beat the Zacks Consensus Estimate of $1.77. Improved sales and margins can be attributable to the increase.

Net sales advanced 5.2% to nearly $414 million and surpassed the Zacks Consensus Estimate of $384 million. The upside was driven by a 5.7% rise in the core business, a 25% increase in online sales and 3.8% growth in Leadership brands.

Notably, core business growth was supported by improved brick and mortar sales in the Housewares unit, solid consolidated online sales and strong appliance sales in the Beauty division. These were offset by soft Health & Home segment sales and sluggishness in the personal care business in the Beauty segment. Additionally, an unfavorable currency movement was a hindrance to the tune of about $1.9 million.

Consolidated gross margin improved 3.6 percentage points (or 50 basis points) to 43%, courtesy of an increased mix of Housewares sales, tariff exclusion refunds and favorable shipment mix. This was partly countered by adverse currency fluctuations, increased inbound freight costs, a smaller mix of personal care sales, and tariff and related pricing impacts.

Adjusted operating income improved 10.4% to $65.8 million and the adjusted operating margin rose 0.8 percentage points to 15.9%.

Segment Performance

Net sales in the Housewares segment advanced 22.1% to $167.9 million, courtesy of growth in point of sale, increased distribution with brick and mortar customers, higher online sales, improved international sales and innovation. These positives were somewhat offset by currency headwinds of about 0.3%. Adjusted operating income in the unit improved 22.1% and the adjusted operating margin was flat at 22.4%.

Net sales in the Health & Home segment declined 9.7% to $158.8 million mainly due to a decline in the core business. Adjusted operating income fell 4.1%, while adjusted operating margin expanded 70 basis points (bps).

Sales in the Beauty segment improved 8.8% to $87.3 million, owing to solid demand and new products in the appliance business, and strong online and international sales. The upside was countered by reduced brick and mortar sales and softness in the personal care business. Adjusted operating income rose 1.3% and while the adjusted operating margin contracted 90 bps.

Other Financial Details & Developments

Helen of Troy ended the quarter with cash and cash equivalents of $17 million and total debt of $301.2 million.

Net cash from operating activities during the first six months of fiscal 2020 came in at $38.2 million.

Fiscal 2020 Outlook

Management is impressed with the company’s second-quarter performance, marked by core sales growth, solid adjusted earnings per share increase and enhanced operating margin. This indicates that the company’s growth investments and digital efforts are yielding results. Further, Helen of Troy is on track with Phase II of its Transformation plan.

Given a robust first half and solid expectations for the remaining part of fiscal 2020, management raised its guidance. Consolidated net sales are now projected to be $1.610-$1.640 billion, indicating growth of 2.9-4.8%. Earlier, the company expected consolidated net sales growth of 1.7-3.6%.

Sales in the Housewares unit are expected to grow 13-15% now compared with 6-8% growth projected earlier. Health & Home net sales are now anticipated to decline low-single digits against the previous expectation of 2-3% growth. Beauty segment net sales are likely to rise low-single digits versus a low–single-digit drop forecasted earlier.

Finally, adjusted earnings from continuing operations are projected to be $8.5-$8.75 per share compared with the earlier view of $8.40-$8.65. The Zacks Consensus Estimate for fiscal 2020 earnings is currently pegged at $8.53.

Price Performance

Shares of this Zacks Rank #3 (Hold) company have gained 30.2% in the past six months compared with the industry’s growth of 14.4%.

Don’t Miss These Cosmetic Stocks

e.l.f. Beauty, Inc. (NYSE:ELF) , with a Zacks Rank #1 (Strong Buy), has an impressive earnings surprise record. You can see the complete list of today’s Zacks #1 Rank stocks here.

Estee Lauder (NYSE:EL) , with a Zacks Rank #2 (Buy), has a long-term earnings per share growth rate of 12.7%.

Avon Products (NYSE:AVP) , also with a Zacks Rank #2, has a long-term earnings per share growth rate of 7.5%.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Helen of Troy Limited (HELE): Free Stock Analysis Report

e.l.f. Beauty Inc. (ELF): Free Stock Analysis Report

The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

Avon Products, Inc. (AVP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.